Table 3.
Mixtures b | Standards (μg/mL) a | |||||
---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | |
1 | EC5 | EC10 | EC20 | EC30 | EC40 | EC50 |
2 | EC10 | EC30 | EC50 | EC5 | EC20 | EC40 |
3 | EC20 | EC50 | EC10 | EC40 | EC5 | EC30 |
4 | EC30 | EC5 | EC40 | EC10 | EC50 | EC20 |
5 | EC40 | EC20 | EC5 | EC50 | EC30 | EC10 |
6 | EC50 | EC40 | EC30 | EC20 | EC10 | EC5 |
7 | EC50 | EC50 | EC50 | EC50 | EC50 | EC50 |
8 | EC5 | EC5 | EC5 | EC5 | EC5 | EC5 |
a Standards 1, 2, 3, 4, 5 and 6 were epimedin A, epimedin B, epimedin C, icariin, baohuoside I and icartin, respectively; b mixtures 1–6 were composed of fixed concentration ratios of six standards through uniform design, and mixtures 7 and 8 were composed of fixed concentration ratios of six standards through the equivalent concentration method.